MedTrace Logo

Using a New Calibrated Tool in Specific Language and Learning Disorders : the BMTi

NCT03919357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 229

Last updated 2021-05-20

No results posted yet for this study

Summary

The group of experts at HAS has defined the places of first and second-line workers in specific disorders of development and learning, as defined in the international diagnostic classifications International Classification of Diseases (CIM) CIM 11 and Diagnostic and Statistical Manual of Mental Disorders (DSM) DSM 5. The referral to a second-level structure, a multidisciplinary structure in charge of carrying out the different cognitive assessments, requires a preliminary evaluation.

This orientation is based on a medical consultation, carried out by a doctor specialized in the field, with an exploration tool adapted to the different fields concerned.

The BMTi, a battery of third-generation tests (after the Rapid battery of evaluation of the cognitive functions (BREV) and then the Evaluation of cognitive functions and learning of the child (EDA)) will enable the doctor, from 2018, to carry out this orientation in a relevant way in response to children with a complaint about neurodevelopment and learning. .

The research project aims to validate this hypothesis, by comparing the diagnoses posed in a conventional way with the various multidisciplinary assessments, with the results of the transfer of all or part of the subtests of the BMTi by a doctor of second resort.

Conditions

  • Learning Disorders, Specific
  • Developmental Disability

Interventions

BEHAVIORAL

BMT-i

Passing the BMT-i test

Sponsors & Collaborators

  • Association pour la recherche des troubles de l'apprentissage

    collaborator UNKNOWN

  • Orthoédition

    collaborator UNKNOWN

  • Association Française de Pédiatrie Ambulatoire- AFPA

    collaborator UNKNOWN

  • Association pour l'Etude du Développement de l'Enfant

    collaborator UNKNOWN

  • Centre Hospitalier Intercommunal Creteil

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-07
Primary Completion
2021-03-01
Completion
2021-04-01

Countries

  • France
  • Martinique

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03919357 on ClinicalTrials.gov